Triglycerides: a case for treatment? : Current Opinion in Cardiology Triglycerides: a case for
treatment? : Current Opinion in Cardiology Log in or Register Subscribe to journalSubscribe Get …

Cardiovascular disease is the leading cause of death in postmenopausal women in Western
countries. Despite preventive strategies, in the past decades, the incidence of …

The evidence linking hypertriglyceridemia and coronary artery disease (CAD) is reviewed. A
positive correlation between plasma triglyceride level and CAD incidence has been …

Background Lipid accumulation product (LAP) is a recently proposed good discriminator for
cardiovascular disease and diabetes. The aim of this study was to clarify how age and …

Purpose: Long‐term treatment with carbamazepine (CBZ) may alter serum lipoprotein
concentrations. Gender‐related examinations, however, are rare and inconsistent in their …

Elevated total cholesterol, the related low-density lipoprotein-cholesterol, high-density
lipoprotein-cholesterol, triglycerides, and smoking habits are risk factors for cardiovascular …

Aims to prospectively evaluate the risk of acute myocardial infarction (AMI) associated with
non-fasting triglyceride levels. Methods a health survey of 140,790 Norwegians free of …

Background Dyslipidemia, which is characterized by an unfavorable lipid profile, is a key risk
factor for cardiovascular disease (CVD). Understanding the relationships between …

Fenofibrate, a fibric acid derivative, is used as adjunctive therapy with diet for treatment of
hyperlipidemia. Side effects include gastrointestinal complaints and, rarely, elevations in …

The increased life expectancy of women living in industrialized countries is associated with
an increase in diseases dependent or facilitated by a state of estrogen deficiency, such as …